– USA, GA – Crawford & Company (NYSE: CRD-A/CRD-B), the world’s largest publicly listed independent provider of claims management and outsourcing solutions today announced the appointment of a current Board member, Michelle Jarrard as non-executive chair of the Board of Directors, effective May 14, 2021.
Charles Ogburn, the current non-executive chair will remain on the Board and will chair the Compensation Committee.
“Michelle’s intelligence, energy and determination are assets to our Board, and as chair, she will serve our company and shareholders well. The fact that she is the first woman to chair Crawford’s Board follows the proud legacy of Virginia Crawford, the company’s first woman director, and adds to our pride and excitement,” said Charles Ogburn, current non-executive chair.
Rohit Verma, CEO, said “I am delighted that Michelle has been named our new Board chair. Since she joined two years ago, her unique perspective has added depth and strength to the Board as a whole. Her expertise has been and will continue to be pivotal as we navigate the extraordinary challenges posed by the pandemic and strive to achieve our envisioned future and purpose to restore and enhance lives, businesses, and communities. I am proud that our Board is one of the most diverse in our sector. I firmly believe that diversity fosters innovation, collaboration, and creativity.”
About Michelle Jarrard
Michelle Jarrard was elected to the Crawford Board in August 2018, bringing with her a combination of experience with innovation, technology, and people. These skills will continue to prove invaluable to Crawford as it builds on its 80-year legacy and financial strength to become the embedded partner of choice for carriers and corporations.
Michelle is a former senior partner of McKinsey & Company, where she held multiple senior leadership roles during her 25-year career, most recently as global chief human resources and talent officer from 2007 until she retires from the firm in January 2016.
“I am honored to be elected Crawford’s Board chair and thank the entire Board for its vote of confidence,” said Michelle Jarrard.
“This is an exciting time for Crawford as it celebrates its 80th anniversary and continues to successfully execute through the pandemic while retaining focus on its strategic pillars, financial performance and people development. I want to thank Charlie Ogburn for his exemplary leadership of our Board, which has set the standard, and I look forward to continuing to work alongside him on the Crawford Board.”
In addition to Crawford & Company, Michelle is the CEO of BioCircuit Technologies, Inc. and a Board member of Lazard Ltd and Inspire Brands. She was a Trustee of Children’s Healthcare of Atlanta (2012-2019) and a Trustee of the Georgia Tech Foundation Board (2014-2019).
Michelle has an MBA from Harvard Business School and a Bachelor of Industrial Engineering from the Georgia Institute of Technology. Michelle has resided in Canada, the U.S., and the UK. She and her husband Jimmy currently live in Atlanta and have two grown children.
About Crawford
Based in Atlanta, Crawford & Company is the world’s largest publicly listed independent provider of claims management and outsourcing solutions to carriers, brokers, and corporations with an expansive global network serving clients in more than 70 countries. The Company’s two classes of stock are substantially identical, except concerning voting rights and the Company’s ability to pay greater cash dividends on the non-voting Class A Common Stock than on the voting Class B Common Stock, subject to certain limitations. In addition, concerning mergers or similar transactions, holders of CRD-A must receive the same type and amount of consideration as holders of CRD-B, unless different consideration is approved by the holders of 75 percent of CRD-A, voting as a class.
For more information: https://www.crawco.com/
- Disclaimer - News, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.
